Independent testing, published RTP ranges, and clear dispute processes are signals that a platform takes integrity seriously
GLP-1 receptor agonists like semaglutide and tirzepatide work differently
Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
Strategies for maintaining weight loss after GLP-1 focus on protein-rich nutrition, consistent exercise, and ongoing monitoring
Vital signs Blood pressure and heart rate were stable during the trial, mean arterial pressure was lower at 12 weeks in the exenatide group compared to placebo, 6.7 mmHg (3.6), P = 0.088, but there was no significant change within arms between baseline and 12 weeks (Supplementary Table 4)
Is Microdosing Right for You